Physician profile
Antonio Falcon
NPI 1538118740
$287.08
in general payments reported to CMS, 2019-2025
12 companies · $14.24 in 2025
The $14.24 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.56 · 2020: $48.35 · 2021: $76.43 · 2023: $34.81 · 2024: $58.69 · 2025: $14.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $107.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $71.80 | 2020-2021 | |
| Astellas Pharma US INC | $39.66 | 2019 | |
| Nevro Corp. | $21.94 | 2024 | Senza |
| Abbvie INC. | $21.63 | 2023 | |
| Dexcom, INC. | $20.33 | 2024 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $19.94 | 2020 | |
| Medtronic, INC. | $18.19 | 2021 | |
| Tactile Systems Technology INC | $16.42 | 2024 | Flexitouch Plus, Entre Plus |
| Abbott Laboratories | $14.90 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.85 | 2021 | |
| Amgen INC. | $14.24 | 2025 | Otezla, Repatha |
| Phadia US INC. | $13.18 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Falcon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.